LC-MS

The 4th Workshop on
Recent Issues in Regulated Bioanalysis

"Discussing, Reviewing, Sharing Perspectives, Providing Potential Solutions and Agreeing upon a Consistent Approach
on the Recent Issues in Regulated Bioanalysis "

April 22-23, 2010, Montreal, Canada
Short Courses: April 20-21, 2010
Hotel Marriott Chateau Champlain

Highlights  |   Workshop Final Program   |   Pre-Workshop Short Courses   |   Workshop White Papers   |   Sponsors  

 

Pre-Workshop Short Courses

Short Course 1 (half day): 1pm to 5pm, April 20, 2010
Fundamental of Bioanalysis: Bioanalytical Method Validation (BMV) and Sample Analysis for Chromatographic and Ligand Binding Assays (LBA)

Bioanalytical Method Validation: "History & Definitions"

  • Definition of Bioanalytical Method Validation
  • Regulatory Guidance on Bioanalytical Method Validation from Crystal City I to Crystal City III
  • FDA Guidance for the Industry, Bioanalytical Method Validation (May 2001)
  • FDA Good Laboratory Practice for Nonclinical Laboratory Studies: Title 21, Code of Federal Regulations, Part 58
  • OECD Principles on Good Laboratory Practice (as revised in 1997)
  • Drugs Directorate Guidelines, "Conduct and Analysis of Bioavailability and Bioequivalence Studies"
  • Statistics in Bioanalysis
    • Statistical Mean
    • Standard Deviation and Relative Standard Deviation
    • Deviation from Theoretical and Percent Difference
    • Correlation Coefficient
    • Rejection of Outliers with T-test
  • GLP Definitions
  • Key Terms & Concepts in Bioanalysis
  • GLP Documentation
    • Analytical Method
    • Data Review

Bioanalytical Method Validation: "Criteria & Concepts"

  • The Validation Process and the Validation Goals
  • Uncertainty in Quantitative Analysis
  • Validation Parameters and Method Validation
    • Accuracy and Precision
    • Analysis of Variance (ANOVA)
    • Assessing Accuracy and Precision
    • Stability Tests
    • Recovery
  • Approaches to Quantification
    • Calibration Curve
      • Limit of Quantification (LLOQ & ULOQ) and other Key Terms
      • Quantitative Relationships in MS Instruments
      • Nature of Regression Errors
    • Standard Addition
  • Defining Acceptance Criteria
  • Essential Documentation
  • System Suitability and its Importance
  • The Steps in a Typical MS Quantitative Analysis
  • Routine Sample Analysis

LC-MS/MS & Bioanalysis

  • Why LC-MS/MS?
    • Advantages & Disadvantages of using LC-MS/MS in Bioanalysis
  • Professor Fred McLafferty’s Four S’s of LC-MS Analysis
  • Internal Standard
    • Importance of Choosing the best Internal Standard
    • Analogue vs. Stable Labeled Internal Standards
  • Sample Preparation Pros and Con
    • Protein Precipitation (PPT)
    • Liquid-Liquid Extraction (LLE)
    • Solid Phase Extraction (SPE)
  • Matrix Effect and Ion Suppression/Enhancement Definitions
  • Carryover Definition

Ligand Binding Assays (LBA) & Bioanalysis

  • A Special Case: Quantitative Analysis of Therapeutic Bioactive Proteins
  • Background and basics
    • Yalow & Berson
    • Antibodies and Antigens
  • Types of Immunoassays
    • Competitive Immunoassay
    • Non-competitive Immunoassay
    • Heterogeneous vs Homogenous Immunoassays
    • RIA,EIA,FPIA, KIMS, Lateral Flow
    • ELISA
  • LBA: Strenghta and Limitations
  • Cross-Reactivity Issues
  • Testing Formats and Models
  • LC-MS/MS vs. LBA
    • Types of LBA Protocols
    • Reagents vs. Equipment
    • Detector System
    • Reference Standard
    • Calibration Courve & Prozone
    • Assay Validation Parameters
    • Matrix interference

Short Course 2 (full day): 8am to 4pm, April 21, 2010
Regulated Bioanalysis: Challenges Solutions and Applications

Bioanalytical Method Validation and Sample Analysis: "Common Problems"

  • Matrix Effect and Ion Suppression/Enhancement
    • Matrix Effect in Electrospray (ESI) LC-MS/MS
    • Remedy for Ionization Suppression in SPE-LC-ESI-MS/MS
    • Matrix Induced Ionization Suppression in APCI
    • Differential Suppression
      • The 3 Different Scenarios of Matrix Effect
      • Instrument Optimization to Reduce Matrix Effect
  • Carry-Over Guidelines
    • Impact of Carry-Over in Bioanalysis
    • Fighting Carry-Over
  • Drug Metabolism & Bioanalysis
    • Metabolite Conversion During Sample Extraction
    • Metabolite Conversion During Instrumental Analysis
    • General Strategy for Method using UV or Fluorescence Detection
    • General Strategy for Method using MS or MS/MS
    • Study Cases
  • Root Cause Analysis during Out of Specification investigation
    • Importance of Trend Analysis in GLP Bioanalysis

What's new in Bioanalysis?

  • The Purpose of the 3rd AAPS/FDA Bioanalytical Workshop
  • Crystal City III Conclusions
    • Quality Controls: Conventional and New Approaches
    • Evaluating Curve Models: Graphic & Mathematical Comparison
    • Factors Contributing to Imprecision and/or Inaccuracy
    • Carryover and Contamination Evaluation
      • Contamination criteria
    • Evaluate Contamination in Validation
    • Incurred Sample Re-Analysis (ISR)
      • Reproducibility of QC vs. Incurred Samples
      • Approach for ISR
    • Determination of Metabolites During Drug Development
    • Documentation Issues
    • Repeat Analyses
    • Matrix Effects for MS-Based Assays
    • Run Acceptance Criteria
    • Stability Recommendations
    • Autosampler Re-injection Reproducibility
    • Blood Stability
    • Method Evolution & Stability Measurements
    • Internal Standard Stability
    • Validation Topics with No Consensus:
      • -70oC vs. - 20oC
      • Reference Standard Expiration Date vs. Stock Stability
  • Other Validation tests
  • Analytical investigations
  • Pharmacokinetic repeats
  • Challenges in bioanalytical method development
  • Impact of metabolites on method development
  • Matrix Effects and Hemolysis Effect
  • Autosampler stability and re-injection reproducibility
  • Acceptance of nonlinear calibration models
  • Instruments/Techniques that Can Improve Quality in Regulated Bioanalysis
  • Concept Paper/ Recommendations on the Need for a Guideline on the Validation of Bioanalytical Methods
  • Metabolite Testing & MIST
  • Specificity in Presence of OTC Metabolites
  • Use of Variable Injection Volumes
  • Anticoagulants
    • Cross-Validation Between Different Anticoagulant Salt Forms

 

 

©2008 Canadian LC-MS Group. All Rights Reserved.
+1 (514) 236-4225   |   contact@canadianlcmsgroup.com